A throng of more than 50 world-class investigators from some of Georgia’s top research institutions gathered recently at the Georgia Institute of Technology to kick off a new initiative – the first symposium of the Georgia Concussion Research Consortium.
Melissa Kemp has joined the Modeling and Analysis of Biological Systems Study Section of the Center for Scientific Review (CSR), the gateway for grant applications and their review for scientific merit at the National Institutes of Health.
The National Neurotrauma Society (NNS) has selected Michelle LaPlaca, associate professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, as its president-elect for the term 2019-2020.
The Coulter Translational Program, in partnership with the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, awarded $765,000 to six biomedical research projects. These awards help bring innovations in patient care into the marketplace.
Implantation of a stent-like flow diverter can offer one option for less invasive treatment of brain aneurysms – bulges in blood vessels – but the procedure requires frequent monitoring while the vessels heal.
An intensive whirlwind year of study and productivity ended last week for 34 new graduates of the Master in Biomedical Innovation and Development program, who wrapped up their final projects and live presentations for assembled clinicians, faculty, industry leaders, fellow and former students.
Bilal Haider, assistant professor in the Wallace H.
Biomedical engineer Yonggang Ke, Ph.D., and colleagues at UC Davis and University of Washington were awarded a grant from the National Science Foundation to create DNA-based electrically readable memories.
The dream took hold when Ignacio Montoya was six-years-old and leaving his native Cuba, leaving behind his family, language, and culture. It happened right there on the Boeing airplane carrying he and his father to the United States.
James Dahlman, assistant professor in the Wallace H.
The Petit Institute for Bioengineering and Bioscience at the Georgia Institute of Technology experienced a dramatic expansion with the addition of 20 new faculty researchers.
The vision of making affordable, high-quality cell-based therapies available to hundreds of thousands of patients worldwide moved closer to reality June 6 with the dedication of a new cell manufacturing research facility at Georgia Tech aimed at changing the way we think about medical therapies.
Two multidisciplinary research teams have been awarded 2018 Petit Institute Seed Grants.
The National Science Foundation (NSF) has selected Georgia Tech Professor Branislav Vidakovic, who holds a joint appointment in the Stewart School of Industrial and Systems Engineering (ISyE) and the Wallace H.
Johnna Temenoff has been appointed to the Carol Ann and David D. Flanagan endowed professorship. Temenoff is a professor in the Wallace H.
Last year, commercial medical history was made when the Food and Drug Administration (FDA) approved the first gene therapy treatment, Kymriah, in the U.S., opening the door to a new world of treatment for devastating diseases.
Two years ago, Daniel Porada was sitting in a biology class at Columbia University when he came up with the idea for Synapse. He saw a way to leverage the krebs cycle (the process by which cells generate energy) for an energy drink.
A new national project, which includes the Georgia Institute of Technology, aims to convey the benefits of physics’ age-old intertwining with math upon biology, a science historically less connected with it.
Now in its sixth year, Project ENGAGES at the Georgia Institute of Technology has been around long enough to have some established traditions.
Ting works across multiple disciplines to advance mobility.